Literature DB >> 15932520

Epitope analysis of insulin autoantibodies using recombinant Fab.

C J Padoa1, N J Crowther, J W Thomas, T R Hall, L M Bekris, C Torn, M Landin-Olsson, E Ortqvist, J P Palmer, A Lernmark, C S Hampe.   

Abstract

Autoantibodies to insulin are often the first autoantibodies detected in young children with type 1 diabetes and can be present before the onset of clinical diabetes. These autoantibodies and their epitopes are, however, not well characterized. We explored the use of monoclonal antibodies and their recombinant Fab as reagents for epitope analysis. In this study we cloned and characterized the recombinant Fab of the insulin-specific monoclonal antibody CG7C7. We found the epitope of this antibody to be located predominantly at the A-chain loop of the insulin molecule. The recombinant Fab was then used to compete for insulin binding against insulin autoantibodies present in sera from patients with type 1 or type 1.5 diabetes. In competition experiments with sera positive for autoantibodies to insulin the recombinant Fab significantly reduced the binding to [125I]-insulin by sera of type 1 (n = 35) and type 1.5 diabetes [latent autoimmune diabetes in adults (LADA)] (n = 14) patients (P < 0.0001). We conclude that competition between insulin-specific monoclonal antibodies or their recombinant Fab and insulin autoantibodies should prove useful in the epitope analysis of autoantibodies to insulin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932520      PMCID: PMC1809383          DOI: 10.1111/j.1365-2249.2005.02802.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

1.  A novel monoclonal antibody specific for the N-terminal end of GAD65.

Authors:  C S Hampe; P Lundgren; T L Daniels; L P Hammerle; S M Marcovina; A Lernmark
Journal:  J Neuroimmunol       Date:  2001-02-01       Impact factor: 3.478

2.  Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.

Authors:  M Pietropaolo; E Barinas-Mitchell; S L Pietropaolo; L H Kuller; M Trucco
Journal:  Diabetes       Date:  2000-01       Impact factor: 9.461

3.  Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

Authors:  C S Hampe; L P Hammerle; L Bekris; E Ortqvist; I Kockum; O Rolandsson; M Landin-Olsson; C Törn; B Persson; A Lernmark
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

4.  Prognostic factors for the course of beta cell function in autoimmune diabetes.

Authors:  C Törn; M Landin-Olsson; A Lernmark; J P Palmer; H J Arnqvist; G Blohmé; F Lithner; B Littorin; L Nyström; B Scherstén; G Sundkvist; L Wibell; J Ostman
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

5.  Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage.

Authors:  C Törn; M Landin-Olsson; A Lernmark; B Scherstén; J Ostman; H J Arnqvist; E Björk; G Blohmé; J Bolinder; J Eriksson; B Littorin; L Nyström; G Sundkvist
Journal:  Autoimmunity       Date:  2001       Impact factor: 2.815

6.  The World Health Organization International Collaborative Study for islet cell antibodies.

Authors:  A R Mire-Sluis; R Gaines Das; A Lernmark
Journal:  Diabetologia       Date:  2000-10       Impact factor: 10.122

7.  GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.

Authors:  H Reijonen; T L Daniels; A Lernmark; G T Nepom
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

8.  Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody.

Authors:  P G Colman; C Steele; J J Couper; S J Beresford; T Powell; K Kewming; A Pollard; S Gellert; B Tait; M Honeyman; L C Harrison
Journal:  Diabetologia       Date:  2000-02       Impact factor: 10.122

9.  Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen.

Authors:  V Kolm-Litty; S Berlo; E Bonifacio; M Bearzatto; A M Engel; M Christie; A G Ziegler; T Wild; J Endl
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

10.  Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes.

Authors:  Jinko Graham; William A Hagopian; Ingrid Kockum; Lou Sheng Li; Carani B Sanjeevi; Robert M Lowe; Jonathan B Schaefer; Marjan Zarghami; Heather L Day; Mona Landin-Olsson; Jerry P Palmer; Marta Janer-Villanueva; Leroy Hood; Göran Sundkvist; Ake Lernmark; Norman Breslow; Gisela Dahlquist; Göran Blohmé
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

View more
  7 in total

1.  Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!

Authors:  O Rolandsson; J P Palmer
Journal:  Diabetologia       Date:  2010-03-25       Impact factor: 10.122

2.  Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes.

Authors:  T R Hall; J W Thomas; C J Padoa; C Torn; M Landin-Olsson; E Ortqvist; C S Hampe
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

3.  GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.

Authors:  Camilla Skoglund; Mikael Chéramy; Rosaura Casas; Johnny Ludvigsson; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2011-08-16       Impact factor: 4.866

4.  Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.

Authors:  C S Hampe; T R Hall; A Agren; O Rolandsson
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

5.  Primary Immune Responses and Affinity Maturation Are Controlled by IgD.

Authors:  Timm Amendt; Omar El Ayoubi; Alexandra T Linder; Gabriele Allies; Marc Young; Corinna S Setz; Hassan Jumaa
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

6.  Etiopathogenesis of insulin autoimmunity.

Authors:  Norio Kanatsuna; George K Papadopoulos; Antonis K Moustakas; Ake Lenmark
Journal:  Anat Res Int       Date:  2012-02-22

7.  Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora.

Authors:  Sergueï O Fetissov; Maria Hamze Sinno; Moïse Coëffier; Christine Bole-Feysot; Philippe Ducrotté; Tomas Hökfelt; Pierre Déchelotte
Journal:  Nutrition       Date:  2008-02-08       Impact factor: 4.008

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.